Related Experiment Video
Updated: Oct 4, 2025

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
Canonical phospholipase D isoforms in visual function and ocular response to stress
Vicente Bermúdez1, Paula E Tenconi1, Norma M Giusto1
1Instituto de Investigaciones Bioquímicas de Bahía Blanca (INIBIBB), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 8000, Bahía Blanca, Argentina; Departamento de Biología, Bioquímica y Farmacia (DBByF), Universidad Nacional del Sur (UNS), 8000, Bahía Blanca, Argentina.
Phospholipase D (PLD) enzymes, PLD1 and PLD2, generate lipid messengers impacting eye health. Inhibiting PLD shows therapeutic potential for retinal inflammation and ocular surface issues, while modulation may aid corneal healing.
Area of Science:
- Biochemistry
- Cell Biology
- Ophthalmology
Background:
- Classical phospholipase D (PLD) isoforms, PLD1 and PLD2, generate lipid messengers like phosphatidic acid (PA) and diacylglycerol (DAG).
- The PLD pathway influences critical cellular events including proliferation, membrane trafficking, autophagy, and inflammatory responses.
Purpose of the Study:
- To review the role of canonical PLD isoforms in physiological and pathological ocular responses.
- To explore the therapeutic potential of targeting the PLD pathway in various eye conditions.
Main Methods:
- Literature review summarizing existing research on PLD1 and PLD2 in ocular biology.
- Analysis of studies investigating the effects of PLD modulation on ocular stress, inflammation, and healing.
Main Results:
- The PLD pathway's role in ocular stress responses requires further elucidation.
- Pharmacological inhibition of PLD enzymes may prevent retinal inflammation, abnormal ocular surface proliferation, and pathological neovascularization.
- Modulating classical PLDs could enhance corneal healing processes.
Conclusions:
- Understanding PLD1 and PLD2's function in ocular diseases offers new therapeutic strategies.
- Targeting PLD offers potential for treating inflammatory and degenerative eye conditions.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Photoreceptors and Visual Pathways
Amplifying Signals via Second Messengers
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

